Elevance Health Inc
(ELV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,661,000 | 5,971,000 | 5,991,000 | 5,888,000 | 6,149,000 |
| Depreciation Amortization | 1,546,000 | 1,393,000 | 1,745,000 | 1,675,000 | 1,302,000 |
| Income taxes - deferred | -279,000 | -374,000 | -602,000 | -115,000 | 342,000 |
| Accounts receivable | -2,526,000 | -683,000 | -1,762,000 | -2,510,000 | -2,138,000 |
| Accounts payable and accrued liabilities | 228,000 | -1,840,000 | 147,000 | 2,411,000 | 2,523,000 |
| Other Working Capital | -3,277,000 | -1,719,000 | -535,000 | 423,000 | 1,123,000 |
| Other Operating Activity | 2,937,000 | 3,060,000 | 3,077,000 | 627,000 | -937,000 |
| Operating Cash Flow | $4,290,000 | $5,808,000 | $8,061,000 | $8,399,000 | $8,364,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -385,000 | 73,000 | 78,000 | -301,000 | -956,000 |
| PPE Investments | -1,116,000 | -1,256,000 | -1,296,000 | -1,152,000 | -1,087,000 |
| Net Acquisitions | 88,000 | -4,446,000 | -1,552,000 | -649,000 | -3,476,000 |
| Purchase Of Investment | -15,026,000 | -17,986,000 | -16,236,000 | -24,946,000 | -18,669,000 |
| Sale Of Investment | 15,095,000 | 18,572,000 | 13,536,000 | 22,608,000 | 14,613,000 |
| Other Investing Activity | 0 | -124,000 | -102,000 | -120,000 | -63,000 |
| Investing Cash Flow | $-1,344,000 | $-5,167,000 | $-5,572,000 | $-4,560,000 | $-9,638,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,203,000 | -438,000 | 262,000 | 2,600,000 | 1,955,000 |
| Debt Issued | 2,991,000 | 7,710,000 | 2,574,000 | 3,071,000 | 3,462,000 |
| Debt Repayment | -2,147,000 | -1,650,000 | -1,909,000 | -1,899,000 | -1,068,000 |
| Common Stock Issued | 79,000 | 221,000 | 152,000 | 182,000 | 203,000 |
| Common Stock Repurchased | -2,605,000 | -2,900,000 | -2,676,000 | -2,316,000 | -1,900,000 |
| Dividend Paid | -1,529,000 | -1,508,000 | -1,395,000 | -1,229,000 | -1,104,000 |
| Other Financing Activity | -1,730,000 | -242,000 | -357,000 | -1,727,000 | -1,125,000 |
| Financing Cash Flow | $-1,738,000 | $1,193,000 | $-3,349,000 | $-1,318,000 | $423,000 |
| Exchange Rate Effect | -5,000 | -6,000 | -1,000 | -14,000 | -10,000 |
| Beginning Cash Position | 8,288,000 | 6,460,000 | 7,387,000 | 4,880,000 | 5,741,000 |
| End Cash Position | 9,491,000 | 8,288,000 | 6,526,000 | 7,387,000 | 4,880,000 |
| Net Cash Flow | $1,203,000 | $1,828,000 | $-861,000 | $2,507,000 | $-861,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,290,000 | 5,808,000 | 8,061,000 | 8,399,000 | 8,364,000 |
| Capital Expenditure | -1,116,000 | -1,256,000 | -1,296,000 | -1,152,000 | -1,087,000 |
| Free Cash Flow | 3,174,000 | 4,552,000 | 6,765,000 | 7,247,000 | 7,277,000 |